08:00
|
SESSION 1 - HADRON THERAPY OVERVIEW
(until 11:30)
()
|
08:00
|
Participants registration
()
|
08:45
|
Welcome Addresses
()
|
09:15
|
Historic and scientific evolution of Hadron Therapy
-
Sandro Rossi
(CNAO)
Ugo Amaldi
(TERA Foundation (IT))
()
|
09:35
|
Hadron Therapy in clinical practice
-
Sara Lillo
(CNAO)
()
|
09:55
|
Radiobiology of Hadron Therapy
-
Angelica Facoetti
(CNAO)
()
|
10:15
|
HITRIplus project, its impact on boosting research in South East Europe and future perspectives
-
Sanja Damjanovic
(SEEIIST Association (CH) / GSI)
()
|
10:35
|
Building capacity through the IAEA programs
-
Sotirios Charisopoulos
(IAEA)
()
|
10:55
|
--- Coffee Break ---
|
11:30
|
SESSION 2 – HADRON THERAPY DEVELOPMENTS AND FUTURE PERSPECTIVES
(until 15:00)
()
|
11:30
|
Hadron Therapy : from pioneering times towards the future
-
Manjit Dosanjh
(University of Oxford (GB))
()
|
11:50
|
SEEIIST facility design and alternatives
-
Maurizio Vretenar
(CERN)
()
|
12:10
|
CERN as an example of large scale infrastructure
-
Emmanuel Tsesmelis
(CERN)
()
|
12:30
|
Status and vision of the SEEIIST project
-
Leandar Litov
(University of Sofia - St. Kliment Ohridski (BG))
()
|
12:50
|
Concluding remarks
-
Roberto Orecchia
(IEO)
()
|
13:00
|
Round table – SEEIIST towards to the Future
()
|
13:45
|
--- Lunch Break ---
|
|
09:00
|
Session 5 – INDICATIONS FOR HADRON THERAPY
(until 11:30)
()
|
09:00
|
Chordoma treatments at CNAO
-
Maria Rosaria Fiore
(CNAO)
()
|
09:25
|
Sarcoma treatments in Greece
-
Tasos Kyriazoglou
(Attikon University Hospital)
()
|
09:45
|
Radiosurgery for Skullbase Meningiom
-
Christos Boskos
(ST. LUKE'S)
()
|
10:05
|
SRS Treatment Planning for Endocranial Tumor
-
Anna Makridou
()
|
10:25
|
Personalization of hadron therapy for radioresistant cancers through bioindicators of radioresistance or conditional vulnerability
-
Michael Story
(Mayo Clinic)
()
|
10:50
|
Concluding remarks
-
Arnold Pompos
(UT Southwestern, Dallas, TX)
Joao Seco
(DKFZ)
()
|
11:05
|
--- Coffee Break ---
|
11:30
|
SESSION 6 – SOCIO-ECONOMIC ASPECTS RELATED TO HADRON THERAPY
-
Sandro Rossi
(Fondazione CNAO)
(until 15:00)
()
|
11:30
|
Hadrontherapy and EU clinical networks: status and perspectives
-
Lisa Licitra
(CNAO, Uni Milan)
()
|
11:50
|
Costs of hadrontherapy, the ABC analysis applied to operations in CNAO
-
Maria Vittoria Livraga
(CNAO)
()
|
12:10
|
Caring for cancer patients: the CNAO social approach
-
Silvia Meneghello
(CNAO)
()
|
12:30
|
The role of citizens in innovating health
-
Katerina Zourou
(Web2Learn)
Stefania Oikonomou
(Web2Learn)
()
|
12:45
|
The role of biomedical and clinical engineering societies in advancing and promoting Hadron Therapy on a national and international level
-
Alkinoos Athanasiou
(AUTH, ELEVIT)
()
|
13:00
|
Challenges and Opportunities in the Patient's Pathway to Access
-
Menia Koukougianni
(NGO KARKINAKI)
()
|
13:20
|
Empowering patient advocacy and cancer prevention
-
Panagiotis Bamidis
(AUTH/AHEPA, ELEVIT)
()
|
13:35
|
Concluding remarks
-
Sandro Rossi
(CNAO)
()
|
13:40
|
--- Lunch Break ---
|
|
15:00
|
SESSION 3 – EXPERIENCES OF MULTIPARTICLE THERAPY FACILITIES IN OPERATION IN EUROPE
(until 17:00)
()
|
15:00
|
Hadron Therapy at GSI - where we come from, where we go
-
Konrad Lehmann
(GSI)
()
|
15:25
|
The HIT facility, technology, clinical applications and research: novel approaches in particle therapy
-
Andrea Mairani
(HIT)
()
|
15:50
|
The Krakow Hadron Therapy facility, lessons learnt
-
Pawel Olko
(IFJ - PAN)
()
|
16:15
|
Concluding remarks
-
Angelica Facoetti
(CNAO)
()
|
16:30
|
--- Coffee Break ---
|
17:00
|
SESSION 4 – ADVANCES IN ACCELERATOR TECHNOLOGIES FOR HADRON THERAPY FACILITIES
(until 22:20)
()
|
17:00
|
Accelerator and beam physics developments for medical and societal applications at CERN
-
Alessandra Lombardi
(CERN)
()
|
17:20
|
Innovative gantry designs: Superconducting magnets for advanced gantry
-
Ernesto De Matteis
(INFN)
()
|
17:35
|
Innovative gantry designs-continued
-
Ariel Haziot
(CERN)
()
|
17:50
|
Optimisation for pre-injectors for hadron therapy-AM
-
Aristeidis Mamaras
(Aristotle University of Thessaloniki / CERN)
()
|
18:10
|
An ion source project as a seed to build capacity for next generation accelerator physicists in Bosnia-and-Herzegovina
-
Medina Dugonjic
(UNSA)
Naida Ustavdic
(UNSA)
Danis Bradaric
(UNSA)
Amer Ajanovic
(CERN/UNSA)
()
|
18:25
|
Development of the first table-top X-ray FLASH system
-
Joao Seco
(DKFZ) Ms
ELPIDA THEODORIDOU
(DKFZ / Uni Malta)
()
|
18:40
|
Concluding remarks
-
Laura Vallow
(Mayo Clinic)
()
|
20:00
|
Welcome, Music event and Welcome Drink
()
|
|
15:00
|
SESSION 7 – PEDIATRIC ONCOLOGY AND ROLE OF HADRON THERAPY
(until 18:45)
()
|
15:00
|
Carbon Programme in MedAustron
-
Piero Fossati
(MedAustron)
()
|
15:15
|
Pediatric Treatments in MedAustron
-
Carola Lütgendorf-Caucig
(MedAustron)
()
|
15:30
|
Hadron therapy state-of-the art in pediatric oncology-clinical aspects
-
Sabina Vennarini
(CNAO)
()
|
15:45
|
Treatment planning for pediatric cancer tumour treatments
-
Alfredo Mirandola
(CNAO)
()
|
16:00
|
Pediatric brain tumour surgery : where do we stand?
-
Nikos Foroglou
(AUTH/AHEPA)
()
|
16:15
|
Role of surgery in pediatric soft tissue sarcoma
-
Aikaterini Tzantzaroudi
(Hippokration Hospital)
()
|
16:30
|
--- Coffee Break ---
|
17:00
|
Panel discussion: Paediatric Oncology in Greece
()
|
17:01
|
Clinical profile of pediatric oncology patients managed and treated in Pediatric Haematology and/or Oncology Unit University Hospital AHEPA
-
Emmanouel Chatzipantelis
(AUTH/AHEPA)
()
|
17:15
|
Clinical profile of pediatric oncology patients managed and treated in Pediatric Haematology and/or Oncology Unit Hospital Hippoktateio Hospital
-
Evgenia Papakonstantinou
(Hippokrateio Hospital)
()
|
17:30
|
Pediatric patients commonly referred for external beam Radiotherapy
-
Eftychia Tataridou
(Theageneio Hospital)
Antonio Capizzello
(AUTH / AHEPA)
()
|
17:45
|
The spectrum of pediatric patients referred for Protontherapy
-
Barbara Rombi
(APSS - TRENTO)
()
|
18:00
|
Radiation treatment plan for pediatric cancer: a clinical view
-
George Giakoumetis
(AUTH/AHEPA)
()
|
18:15
|
Concluding remarks
-
Semi Harrabi
(HIT)
()
|
|